HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SINO BIOPHARM

6.840

+0.1902.86%

Volume:30.88M

Turnover:210.56M

Market Cap:128.33B

PE:31.49

High:6.870

Open:6.660

Low:6.660

Close:6.650

52wk High:9.120

52wk Low:3.107

Shares:18.76B

HK Float Shares:18.76B

Volume Ratio:1.16

T/O Rate:0.16%

Dividend:0.09

Dividend Rate:1.38%

EPS(LYR):0.217

ROE:15.40%

ROA:5.07%

PB:3.39

PE(LYR):31.49

PS:3.70

Loading ...

Overview Company News Filings

Sino Biopharmaceutical Stock Rises 1.8% in Hong Kong

BRIEF-Sino Biopharmaceutical Says NMPA Approved Benmelstobart Injection For Marketing

Sino Biopharm (1177) Announces Approval of Benmelstobart Injection for NSCLC Maintenance Therapy

Bulletin Express

SINO BIOPHARM's Innovative Drug Bemusubain Injection Gains Approval for New NSCLC Indication

Sino Biopharmaceutical - Approval for Marketing of Benmelstobart Injection by China's Nmpa

THOMSON REUTERS

Sino Biopharmaceutical Gains NMPA Approval for Benmelstobart in Stage III NSCLC Maintenance Therapy

Sino Biopharmaceutical Stock Slips 0.9% in Hong Kong, Underperforms Competitors

Sino Biopharmaceutical Stock Sheds 3.7% in Hong Kong, Underperforms Competitors

Bank of America Securities Reaffirms Buy Rating on Sino Biopharm Following Positive Progress on Two Drug Candidates

Small Nucleic Acids Reshape Weight Loss Paradigm with INHBE and ALK7 Targets Showing Initial Validation

Stock Track | SINO BIOPHARM Soars 5.00% Intraday on Completion of Phase III Trial Enrollment for Breast Cancer Drug

Sino Biopharmaceutical Completes Subject Enrollment in Phase 3 Trial of Breast Cancer Drug

MT Newswires Live

Chinese Pharmaceutical Firm Completes Patient Enrollment for Phase III Trial of HER2-Targeting Drug

Sino Biopharm (1177) Completes Phase III Enrollment for TQB2102 “HER2 Bispecific ADC” in HER2-Low Breast Cancer

Bulletin Express

Sino Biopharm Completes Enrollment for Phase III Trial of HER2 Bispecific ADC in HER2-Low Breast Cancer

Sino Biopharmaceutical Stock Rallies 1.9% in Hong Kong, Outperforms Competitors

BUZZ-Sino Biopharm climbs most in five weeks on cancer drug development progress

SINO BIOPHARM (01177): Patient Enrollment Completed for Phase III Trial of Claudiximab "CLDN18.2 ADC"

Sino Biopharmaceutical (1177) Announces Completion of Phase III Enrollment for Tecotabart Vedotin “CLDN18.2 ADC”

Bulletin Express

Sino Biopharmaceutical Completes Phase III Enrollment for Tecotabart Vedotin in Gastric Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/01177/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01177","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01177\",,,,,undefined,":{"symbol":"01177","market":"HK","secType":"STK","nameCN":"SINO BIOPHARM","latestPrice":6.84,"timestamp":1771834083004,"preClose":6.65,"halted":0,"volume":30877386,"delay":0,"changeRate":0.028571428571428494,"floatShares":18761000000,"shares":18761000000,"eps":0.2172396132825633,"marketStatus":"Closed","change":0.19,"latestTime":"02-23 16:08:03","open":6.66,"high":6.87,"low":6.66,"amount":210556792,"amplitude":0.031579,"askPrice":6.84,"askSize":362000,"bidPrice":6.83,"bidSize":77000,"shortable":3,"etf":0,"ttmEps":0.24280329314995658,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"listingDate":1070812800000,"exchange":"SEHK","adjPreClose":6.65,"dividendRate":0.013771,"openAndCloseTimeList":[[1771810200000,1771819200000],[1771822800000,1771833600000]],"volumeRatio":1.158139,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SBO.HK","impliedVol":0.4645,"impliedVolPercentile":0.4756},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01177\",,,,,undefined,":{"symbol":"01177","floatShares":18761000000,"roa":"5.07%","roe":"15.40%","lyrEps":0.21724,"volumeRatio":1.158139,"shares":18761000000,"dividePrice":0.094224,"high":6.87,"amplitude":0.031579,"preClose":6.65,"low":6.66,"week52Low":3.107,"pbRate":"3.39","psRate":"3.70","week52High":9.12,"institutionHeld":0,"latestPrice":6.84,"committee":-0.649203,"eps":0.2172396132825633,"divideRate":0.013775,"volume":30877386,"delay":0,"ttmEps":0.24280329314995658,"open":6.66,"prevYearClose":6.18,"prevWeekClose":6.65,"prevMonthClose":6.64,"prevQuarterClose":6.18,"fiveDayClose":6.83,"twentyDayClose":6.57,"sixtyDayClose":6.8,"dividendFrequency":"Q","dividendGrowthYears":0,"dividendGrowthRate":-0.25000000000000006,"fiveYearAvgDividendRate":0.017531577219225006},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01177\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"01177","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-09-01","defaultRemindTime":1756431000000,"name":"中国生物制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-01","currency":"HKD","dateTimestamp":1756396800000,"payDate":"2025-09-23"},{"date":"2025-08-18","symbol":"01177","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-06-16","symbol":"01177","amount":0.04,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-17","defaultRemindTime":1750037400000,"name":"中国生物制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-10","payableDate":"2025-06-17","currency":"HKD","dateTimestamp":1750003200000,"payDate":"2025-07-10"},{"date":"2025-03-20","symbol":"01177","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742434200000,"name":null,"time":"Post Market","dateTimestamp":1742400000000,"actualEps":null},{"date":"2024-09-10","symbol":"01177","amount":0.03,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-09-11","defaultRemindTime":1725931800000,"name":"中国生物制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-04","payableDate":"2024-09-11","currency":"HKD","dateTimestamp":1725897600000,"payDate":"2024-10-04"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01177\",market:\"HK\",,,undefined,":[{"executeDate":"2016-06-17","recordDate":"2016-06-20","paymentDate":"2016-07-06","value":0.015,"currency":"HKD"},{"executeDate":"2016-06-28","recordDate":"2016-06-29","paymentDate":"2016-07-13","value":0.015,"currency":"HKD"},{"executeDate":"2016-09-12","recordDate":"2016-09-13","paymentDate":"2016-09-29","value":0.015,"currency":"HKD"},{"executeDate":"2016-12-05","recordDate":"2016-12-06","paymentDate":"2016-12-19","value":0.015,"currency":"HKD"},{"executeDate":"2017-06-28","recordDate":"2017-06-29","paymentDate":"2017-07-13","value":0.015,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01177\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.5833,"hold":0.0417,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":24,"updateTime":1758556800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01177\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01177","date":"2026-02-20","current":28.193741,"percent":0.717303,"low":4.081901,"twenty":8.757175,"median":20.182765,"eighty":28.920647,"high":61.685664,"avg":20.189028,"sd":11.640944,"marketCap":118880201213},"quantilePoints":[{"date":"2021-02-26","current":58.788258,"twenty":50.29451,"median":51.620038,"eighty":52.588108,"marketCap":162157689039},{"date":"2021-03-05","current":56.545782,"twenty":50.420098,"median":51.774136,"eighty":54.987533,"marketCap":155581189484},{"date":"2021-03-12","current":57.260655,"twenty":50.670382,"median":51.806517,"eighty":56.523353,"marketCap":157272289370},{"date":"2021-03-19","current":58.922145,"twenty":50.72578,"median":51.861937,"eighty":57.761618,"marketCap":161781889065},{"date":"2021-03-26","current":45.655381,"twenty":50.29451,"median":51.834875,"eighty":57.761618,"marketCap":150248149840},{"date":"2021-04-01","current":44.402146,"twenty":49.232534,"median":51.785727,"eighty":57.72338,"marketCap":145740705344},{"date":"2021-04-09","current":46.245526,"twenty":48.491535,"median":51.774136,"eighty":57.445745,"marketCap":152126251713},{"date":"2021-04-16","current":45.843578,"twenty":47.071442,"median":51.620038,"eighty":56.905893,"marketCap":151375010963},{"date":"2021-04-23","current":47.941821,"twenty":46.674186,"median":51.544559,"eighty":56.595223,"marketCap":158699608268},{"date":"2021-04-30","current":47.292985,"twenty":46.892133,"median":51.338718,"eighty":56.478494,"marketCap":157197126770},{"date":"2021-05-07","current":44.686819,"twenty":46.674186,"median":50.949156,"eighty":55.644586,"marketCap":149496909090},{"date":"2021-05-14","current":47.693245,"twenty":46.358223,"median":50.678334,"eighty":54.98161,"marketCap":159450849017},{"date":"2021-05-21","current":49.252593,"twenty":46.446515,"median":50.318638,"eighty":54.739526,"marketCap":164709534262},{"date":"2021-05-28","current":34.796197,"twenty":46.015,"median":49.739468,"eighty":54.493388,"marketCap":161516761078},{"date":"2021-06-04","current":34.961943,"twenty":45.626349,"median":49.242564,"eighty":54.023478,"marketCap":161516761078},{"date":"2021-06-11","current":33.744804,"twenty":45.33083,"median":48.556215,"eighty":53.234644,"marketCap":155882455459},{"date":"2021-06-18","current":31.684335,"twenty":44.686491,"median":48.197481,"eighty":52.95221,"marketCap":145177274782},{"date":"2021-06-25","current":31.663274,"twenty":43.967373,"median":48.122902,"eighty":52.588108,"marketCap":144989464595},{"date":"2021-07-02","current":30.69154,"twenty":35.796618,"median":47.817533,"eighty":52.557854,"marketCap":140294209913},{"date":"2021-07-09","current":28.583686,"twenty":35.31878,"median":47.514473,"eighty":52.379013,"marketCap":130528080173},{"date":"2021-07-16","current":29.160074,"twenty":34.796197,"median":47.414412,"eighty":52.137563,"marketCap":133157422795},{"date":"2021-07-23","current":28.751555,"twenty":33.744804,"median":47.292985,"eighty":51.895074,"marketCap":131279320922},{"date":"2021-07-30","current":27.039046,"twenty":31.787963,"median":47.023101,"eighty":51.861937,"marketCap":123874830618},{"date":"2021-08-06","current":28.500789,"twenty":31.650912,"median":46.804358,"eighty":51.849781,"marketCap":130256261286},{"date":"2021-08-13","current":27.149641,"twenty":31.212428,"median":46.449805,"eighty":51.81997,"marketCap":124250208892},{"date":"2021-08-20","current":25.951827,"twenty":29.568647,"median":46.197194,"eighty":51.793063,"marketCap":118431845636},{"date":"2021-08-27","current":25.551317,"twenty":29.160074,"median":45.882896,"eighty":51.778391,"marketCap":117118021675},{"date":"2021-09-03","current":10.620748,"twenty":28.876855,"median":45.655381,"eighty":51.774136,"marketCap":128003991638},{"date":"2021-09-10","current":10.546903,"twenty":28.583686,"median":45.43354,"eighty":51.737204,"marketCap":127440924226},{"date":"2021-09-17","current":9.908289,"twenty":28.128178,"median":45.28035,"eighty":51.669892,"marketCap":119370291322},{"date":"2021-09-24","current":9.779132,"twenty":27.82689,"median":44.686819,"eighty":51.590126,"marketCap":117868778224},{"date":"2021-09-30","current":10.025874,"twenty":27.27478,"median":44.601887,"eighty":51.56014,"marketCap":121247182695},{"date":"2021-10-08","current":9.186602,"twenty":27.046772,"median":44.130413,"eighty":51.548113,"marketCap":111092433281},{"date":"2021-10-15","current":9.318231,"twenty":26.569923,"median":36.694857,"eighty":51.507128,"marketCap":112761505517},{"date":"2021-10-22","current":9.220183,"twenty":26.170808,"median":35.563772,"eighty":51.434346,"marketCap":112376076242},{"date":"2021-10-29","current":8.887419,"twenty":25.602517,"median":35.364793,"eighty":51.352853,"marketCap":108052495084},{"date":"2021-11-05","current":8.456886,"twenty":10.558373,"median":34.998178,"eighty":51.164241,"marketCap":102987534377},{"date":"2021-11-12","current":8.560231,"twenty":10.416496,"median":34.764786,"eighty":50.984786,"marketCap":104675854613},{"date":"2021-11-19","current":8.91034,"twenty":10.070918,"median":34.408066,"eighty":50.914517,"marketCap":108802859634},{"date":"2021-11-26","current":8.631049,"twenty":9.844574,"median":32.881851,"eighty":50.794169,"marketCap":105426219162},{"date":"2021-12-03","current":8.737756,"twenty":9.729778,"median":31.787963,"eighty":50.680984,"marketCap":106926948261},{"date":"2021-12-10","current":8.646346,"twenty":9.412104,"median":31.673805,"eighty":50.542589,"marketCap":105988992574},{"date":"2021-12-17","current":8.284795,"twenty":9.319774,"median":31.39672,"eighty":50.326681,"marketCap":101486805279},{"date":"2021-12-24","current":8.338086,"twenty":9.192112,"median":31.22719,"eighty":50.196443,"marketCap":102237169828},{"date":"2021-12-31","current":8.333922,"twenty":9.141505,"median":30.384431,"eighty":50.006669,"marketCap":102408380965},{"date":"2022-01-07","current":8.978555,"twenty":8.282213,"median":8.578854,"eighty":8.931855,"marketCap":109910826457},{"date":"2022-01-14","current":9.402408,"twenty":8.355848,"median":8.935267,"eighty":9.27511,"marketCap":115350099439},{"date":"2022-01-21","current":9.274157,"twenty":8.495499,"median":9.134096,"eighty":9.308362,"marketCap":114037171478},{"date":"2022-01-28","current":8.181531,"twenty":8.355848,"median":8.96544,"eighty":9.254892,"marketCap":100345208455},{"date":"2022-02-04","current":8.353845,"twenty":8.333922,"median":8.935267,"eighty":9.242048,"marketCap":102408380965},{"date":"2022-02-11","current":8.398082,"twenty":8.353845,"median":8.585644,"eighty":9.231359,"marketCap":103158625515},{"date":"2022-02-18","current":8.372232,"twenty":8.353845,"median":8.539109,"eighty":9.218737,"marketCap":103346186652},{"date":"2022-02-25","current":7.955221,"twenty":8.320426,"median":8.459805,"eighty":9.215937,"marketCap":98440722082},{"date":"2022-03-04","current":6.997914,"twenty":8.192451,"median":8.399622,"eighty":9.134096,"marketCap":86627835432},{"date":"2022-03-11","current":6.659587,"twenty":7.910139,"median":8.387341,"eighty":9.033931,"marketCap":82315194274},{"date":"2022-03-18","current":7.006091,"twenty":7.259352,"median":8.362252,"eighty":8.978555,"marketCap":86252823158},{"date":"2022-03-25","current":7.371317,"twenty":7.236339,"median":8.351954,"eighty":8.952325,"marketCap":90752970453},{"date":"2022-04-01","current":4.675869,"twenty":7.058972,"median":8.308293,"eighty":8.918209,"marketCap":84106186785},{"date":"2022-04-08","current":4.547747,"twenty":6.942633,"median":8.219605,"eighty":8.830117,"marketCap":81837075137},{"date":"2022-04-14","current":4.387704,"twenty":6.616876,"median":8.186991,"eighty":8.674624,"marketCap":78826492940},{"date":"2022-04-22","current":4.248774,"twenty":6.241316,"median":8.048348,"eighty":8.582928,"marketCap":74903847557},{"date":"2022-04-29","current":4.469038,"twenty":4.692503,"median":7.744517,"eighty":8.568318,"marketCap":77518944479},{"date":"2022-05-06","current":4.081901,"twenty":4.488006,"median":7.565869,"eighty":8.547152,"marketCap":70215607624},{"date":"2022-05-13","current":4.322075,"twenty":4.384485,"median":7.532014,"eighty":8.525703,"marketCap":73016762184},{"date":"2022-05-20","current":4.632904,"twenty":4.384485,"median":7.412742,"eighty":8.466335,"marketCap":79366045852},{"date":"2022-05-27","current":4.680568,"twenty":4.387704,"median":7.259352,"eighty":8.459805,"marketCap":80113020401},{"date":"2022-06-02","current":4.525356,"twenty":4.432565,"median":7.058972,"eighty":8.419371,"marketCap":77872096754},{"date":"2022-06-10","current":4.621539,"twenty":4.4352,"median":7.002002,"eighty":8.402782,"marketCap":78992558577},{"date":"2022-06-17","current":4.735988,"twenty":4.463986,"median":6.662821,"eighty":8.398698,"marketCap":80859994950},{"date":"2022-06-24","current":5.142082,"twenty":4.471352,"median":6.514843,"eighty":8.397313,"marketCap":88142996805},{"date":"2022-06-30","current":5.423776,"twenty":4.472615,"median":6.245656,"eighty":8.391253,"marketCap":92811587738},{"date":"2022-07-08","current":5.73435,"twenty":4.494949,"median":5.753227,"eighty":8.378276,"marketCap":98227153219},{"date":"2022-07-15","current":5.413863,"twenty":4.510715,"median":5.74317,"eighty":8.371172,"marketCap":91877869551},{"date":"2022-07-22","current":5.179385,"twenty":4.519814,"median":5.724312,"eighty":8.360609,"marketCap":87956253168},{"date":"2022-07-29","current":4.986361,"twenty":4.532767,"median":5.592688,"eighty":8.353922,"marketCap":84781611334},{"date":"2022-08-05","current":4.966061,"twenty":4.543731,"median":5.423776,"eighty":8.35271,"marketCap":84221380422},{"date":"2022-08-12","current":4.728381,"twenty":4.557367,"median":5.285894,"eighty":8.341135,"marketCap":80299764039},{"date":"2022-08-19","current":4.642899,"twenty":4.56463,"median":5.258084,"eighty":8.325824,"marketCap":78058840391},{"date":"2022-08-26","current":8.493761,"twenty":4.56647,"median":5.277824,"eighty":8.341135,"marketCap":78058840391},{"date":"2022-09-02","current":8.238862,"twenty":4.578556,"median":5.413863,"eighty":8.355149,"marketCap":75444429469},{"date":"2022-09-09","current":8.208746,"twenty":4.591042,"median":5.480211,"eighty":8.353922,"marketCap":74882486287},{"date":"2022-09-16","current":8.11962,"twenty":4.598745,"median":5.696236,"eighty":8.353089,"marketCap":73385034348},{"date":"2022-09-23","current":7.794047,"twenty":4.606594,"median":5.727415,"eighty":8.344741,"marketCap":69090235901},{"date":"2022-09-30","current":7.678478,"twenty":4.613732,"median":5.752609,"eighty":8.328524,"marketCap":68195810112},{"date":"2022-10-07","current":7.78297,"twenty":4.623812,"median":5.823839,"eighty":8.317285,"marketCap":69119872580},{"date":"2022-10-14","current":8.22397,"twenty":4.634903,"median":6.267354,"eighty":8.303007,"marketCap":72261684970},{"date":"2022-10-21","current":8.894846,"twenty":4.643031,"median":6.606198,"eighty":8.353467,"marketCap":77621247282},{"date":"2022-10-28","current":8.400958,"twenty":4.643734,"median":6.721508,"eighty":8.371879,"marketCap":73185747437},{"date":"2022-11-04","current":8.90828,"twenty":4.646216,"median":7.016023,"eighty":8.396002,"marketCap":78360497256},{"date":"2022-11-11","current":9.100313,"twenty":4.655414,"median":7.236339,"eighty":8.407643,"marketCap":80763059672},{"date":"2022-11-18","current":9.403245,"twenty":4.664392,"median":7.335813,"eighty":8.46442,"marketCap":83165622088},{"date":"2022-11-25","current":8.930799,"twenty":4.668952,"median":7.531332,"eighty":8.525171,"marketCap":78360497256},{"date":"2022-12-02","current":9.296925,"twenty":4.676809,"median":7.555053,"eighty":8.584286,"marketCap":82980809594},{"date":"2022-12-09","current":9.313941,"twenty":4.687945,"median":7.567538,"eighty":8.707566,"marketCap":83904872062},{"date":"2022-12-16","current":9.397407,"twenty":4.719639,"median":7.647562,"eighty":8.81303,"marketCap":84459309543},{"date":"2022-12-23","current":9.086129,"twenty":4.729099,"median":7.698595,"eighty":8.889427,"marketCap":81687122140},{"date":"2022-12-30","current":9.281716,"twenty":4.731254,"median":7.710864,"eighty":8.915011,"marketCap":84459309543},{"date":"2023-01-06","current":9.328055,"twenty":4.734382,"median":7.731498,"eighty":8.96145,"marketCap":85752996997},{"date":"2023-01-13","current":9.843426,"twenty":4.737165,"median":7.764775,"eighty":9.024693,"marketCap":92221434271},{"date":"2023-01-20","current":9.630169,"twenty":4.739933,"median":7.808834,"eighty":9.11954,"marketCap":89449246868},{"date":"2023-01-27","current":9.76745,"twenty":4.741255,"median":7.828,"eighty":9.134096,"marketCap":90742934323},{"date":"2023-02-03","current":9.242159,"twenty":4.749977,"median":7.910139,"eighty":9.14912,"marketCap":86307434478},{"date":"2023-02-10","current":8.939647,"twenty":4.760926,"median":7.994821,"eighty":9.145292,"marketCap":82980809594},{"date":"2023-02-17","current":8.502405,"twenty":4.779418,"median":8.042416,"eighty":9.134096,"marketCap":78175684763},{"date":"2023-02-24","current":8.382439,"twenty":4.784909,"median":8.105078,"eighty":9.13158,"marketCap":76130387334},{"date":"2023-03-03","current":8.590767,"twenty":4.786195,"median":8.138516,"eighty":9.111513,"marketCap":78525547250},{"date":"2023-03-10","current":8.613919,"twenty":8.572182,"median":8.603737,"eighty":8.631438,"marketCap":78156015263},{"date":"2023-03-17","current":8.854074,"twenty":8.686159,"median":14.627146,"eighty":50.137268,"marketCap":81112271159},{"date":"2023-03-24","current":8.653874,"twenty":8.680699,"median":14.555372,"eighty":50.059787,"marketCap":80188441192},{"date":"2023-03-31","current":8.841045,"twenty":8.682095,"median":14.465882,"eighty":50.052946,"marketCap":81297037153},{"date":"2023-04-06","current":26.385992,"twenty":8.683492,"median":14.468662,"eighty":50.046105,"marketCap":76623190314},{"date":"2023-04-14","current":29.091238,"twenty":8.680699,"median":14.463101,"eighty":49.815888,"marketCap":84562460636},{"date":"2023-04-21","current":28.343601,"twenty":8.680699,"median":14.463101,"eighty":49.757313,"marketCap":82346850314},{"date":"2023-04-28","current":27.787899,"twenty":8.680699,"median":14.463101,"eighty":49.691641,"marketCap":80131239992},{"date":"2023-05-05","current":27.186497,"twenty":8.680699,"median":14.463101,"eighty":49.389192,"marketCap":78525547250},{"date":"2023-05-12","current":26.022356,"twenty":8.680699,"median":14.463101,"eighty":49.1783,"marketCap":74645461386},{"date":"2023-05-19","current":25.609528,"twenty":8.680699,"median":14.463101,"eighty":48.945058,"marketCap":72428269463},{"date":"2023-05-25","current":25.452944,"twenty":8.682095,"median":14.465882,"eighty":48.625163,"marketCap":71689205489},{"date":"2023-06-02","current":24.881313,"twenty":8.680699,"median":14.463101,"eighty":48.313875,"marketCap":69841545554},{"date":"2023-06-09","current":25.44461,"twenty":8.680699,"median":14.463101,"eighty":48.13438,"marketCap":71319673502},{"date":"2023-06-16","current":25.567055,"twenty":8.680699,"median":14.463101,"eighty":47.936748,"marketCap":71319673502},{"date":"2023-06-23","current":22.156893,"twenty":8.680699,"median":14.463101,"eighty":47.800493,"marketCap":61469866445},{"date":"2023-06-30","current":22.891344,"twenty":8.680699,"median":14.463101,"eighty":47.612323,"marketCap":62932979993},{"date":"2023-07-07","current":23.003349,"twenty":8.682095,"median":14.465882,"eighty":47.475199,"marketCap":63117534187},{"date":"2023-07-14","current":23.348328,"twenty":8.682095,"median":14.465882,"eighty":47.339122,"marketCap":64963076122},{"date":"2023-07-21","current":23.124147,"twenty":8.682095,"median":14.465882,"eighty":47.120587,"marketCap":64040305154},{"date":"2023-07-28","current":23.882752,"twenty":8.682095,"median":14.465882,"eighty":46.941508,"marketCap":66070401283},{"date":"2023-08-04","current":22.5111,"twenty":8.682095,"median":14.465882,"eighty":46.556098,"marketCap":62379317413},{"date":"2023-08-11","current":21.031429,"twenty":8.682095,"median":14.465882,"eighty":46.490275,"marketCap":57950016768},{"date":"2023-08-18","current":20.109761,"twenty":8.682095,"median":14.465882,"eighty":46.446515,"marketCap":55013725665},{"date":"2023-08-25","current":27.35707,"twenty":8.682095,"median":14.465882,"eighty":46.446515,"marketCap":55381710452},{"date":"2023-09-01","current":26.972418,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":54829733271},{"date":"2023-09-08","current":26.744198,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":53725778910},{"date":"2023-09-15","current":26.901969,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":54461748484},{"date":"2023-09-22","current":26.83754,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":54093763697},{"date":"2023-09-29","current":25.789185,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":52069847368},{"date":"2023-10-06","current":25.16334,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":50781900614},{"date":"2023-10-13","current":25.840139,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":52069847368},{"date":"2023-10-20","current":24.416834,"twenty":8.684889,"median":14.468775,"eighty":46.374329,"marketCap":49125969072},{"date":"2023-10-27","current":26.714516,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":53725778910},{"date":"2023-11-03","current":30.567338,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":61637451832},{"date":"2023-11-10","current":31.39511,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":63293383374},{"date":"2023-11-17","current":34.642006,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":70469086721},{"date":"2023-11-24","current":33.820877,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":69365132360},{"date":"2023-12-01","current":33.323855,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":68629162786},{"date":"2023-12-08","current":30.229794,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":62005436619},{"date":"2023-12-15","current":30.948108,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":63845360554},{"date":"2023-12-22","current":28.291375,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":58325588749},{"date":"2023-12-29","current":30.804548,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":63845360554},{"date":"2024-01-05","current":29.592871,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":60901482258},{"date":"2024-01-12","current":28.772914,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":59245550716},{"date":"2024-01-19","current":26.217575,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":53909771304},{"date":"2024-01-26","current":25.960692,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":53173801730},{"date":"2024-02-02","current":25.634057,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":52437832156},{"date":"2024-02-09","current":26.045455,"twenty":8.684903,"median":14.482873,"eighty":46.363102,"marketCap":53541786517},{"date":"2024-02-16","current":28.187439,"twenty":8.684889,"median":14.468775,"eighty":46.374329,"marketCap":57957603961},{"date":"2024-02-23","current":28.246863,"twenty":8.684889,"median":14.468775,"eighty":46.374329,"marketCap":57773611568},{"date":"2024-03-01","current":27.959549,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":57221634387},{"date":"2024-03-08","current":26.060017,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":53357794123},{"date":"2024-03-15","current":29.321008,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":59981520290},{"date":"2024-03-22","current":27.457347,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":56117680026},{"date":"2024-03-28","current":27.274509,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":55565702846},{"date":"2024-04-05","current":20.502088,"twenty":8.68491,"median":14.545212,"eighty":46.385567,"marketCap":51738890207},{"date":"2024-04-12","current":19.836504,"twenty":8.684917,"median":14.622337,"eighty":46.379948,"marketCap":50087649030},{"date":"2024-04-19","current":17.00797,"twenty":8.684917,"median":14.824165,"eighty":46.379948,"marketCap":42908870597},{"date":"2024-04-26","current":20.158221,"twenty":8.685111,"median":15.006965,"eighty":46.368715,"marketCap":50793833997},{"date":"2024-05-03","current":20.900402,"twenty":8.685111,"median":17.666939,"eighty":46.368715,"marketCap":52627546416},{"date":"2024-05-10","current":22.594528,"twenty":8.68601,"median":19.495478,"eighty":46.368715,"marketCap":57028456221},{"date":"2024-05-17","current":22.482225,"twenty":8.68601,"median":19.836504,"eighty":46.368715,"marketCap":56661713737},{"date":"2024-05-24","current":20.929348,"twenty":8.68601,"median":20.158221,"eighty":46.368715,"marketCap":52627546416},{"date":"2024-05-31","current":20.689517,"twenty":8.68601,"median":20.438856,"eighty":46.368715,"marketCap":52077432691},{"date":"2024-06-07","current":20.788148,"twenty":8.707461,"median":20.694975,"eighty":46.368715,"marketCap":52260803932},{"date":"2024-06-14","current":20.150143,"twenty":8.757175,"median":20.694975,"eighty":46.368715,"marketCap":50610462756},{"date":"2024-06-21","current":19.02184,"twenty":8.763371,"median":20.705001,"eighty":46.368715,"marketCap":47676522886},{"date":"2024-06-28","current":19.542074,"twenty":8.763371,"median":20.705001,"eighty":46.368715,"marketCap":48960121579},{"date":"2024-07-05","current":20.717633,"twenty":8.763371,"median":20.708507,"eighty":46.368715,"marketCap":51894061449},{"date":"2024-07-12","current":21.125844,"twenty":8.763371,"median":20.717171,"eighty":46.368715,"marketCap":52994288900},{"date":"2024-07-19","current":20.833056,"twenty":8.763371,"median":20.76172,"eighty":46.368715,"marketCap":52260803932},{"date":"2024-07-26","current":20.391805,"twenty":8.763371,"median":20.774673,"eighty":46.368715,"marketCap":51343947723},{"date":"2024-08-02","current":20.403694,"twenty":8.763371,"median":20.774673,"eighty":46.368715,"marketCap":51343947723},{"date":"2024-08-09","current":20.920099,"twenty":8.763371,"median":20.788148,"eighty":46.368715,"marketCap":52994288900},{"date":"2024-08-16","current":13.474849,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":59895993625},{"date":"2024-08-23","current":12.806368,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":57165173247},{"date":"2024-08-30","current":13.085579,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":58803665474},{"date":"2024-09-06","current":12.836322,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":57711337322},{"date":"2024-09-13","current":13.073008,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":58621610782},{"date":"2024-09-20","current":13.560082,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":61170376468},{"date":"2024-09-27","current":14.842966,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":67360235991},{"date":"2024-10-04","current":16.724157,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":75552697126},{"date":"2024-10-10","current":15.372928,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":68998728218},{"date":"2024-10-18","current":15.412732,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":68816673526},{"date":"2024-10-25","current":14.435061,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":64447360921},{"date":"2024-11-01","current":14.669834,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":65539689073},{"date":"2024-11-08","current":14.122653,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":62808868695},{"date":"2024-11-15","current":13.694576,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":60260103008},{"date":"2024-11-22","current":13.659673,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":60078048317},{"date":"2024-11-29","current":13.461736,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":59167774857},{"date":"2024-12-06","current":13.618076,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":59713938933},{"date":"2024-12-13","current":13.728207,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":60078048317},{"date":"2024-12-20","current":13.413238,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":58439556090},{"date":"2024-12-27","current":13.507288,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":58803665474},{"date":"2025-01-03","current":12.783861,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":55708735712},{"date":"2025-01-10","current":11.99376,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":52067641874},{"date":"2025-01-17","current":12.179201,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":52915350334},{"date":"2025-01-24","current":11.936992,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":52187991566},{"date":"2025-01-28","current":11.667884,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":51278793107},{"date":"2025-02-07","current":12.358438,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":54006388485},{"date":"2025-02-14","current":13.472496,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":58734220474},{"date":"2025-02-21","current":13.855323,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":60734457084},{"date":"2025-02-28","current":13.401695,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":58552380782},{"date":"2025-03-07","current":13.845547,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":60734457084},{"date":"2025-03-14","current":14.627846,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":64189411230},{"date":"2025-03-21","current":17.171853,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":64449578833},{"date":"2025-03-28","current":17.828023,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":66776924735},{"date":"2025-04-03","current":18.607188,"twenty":8.758254,"median":20.78141,"eighty":46.385567,"marketCap":69557715461},{"date":"2025-04-11","current":17.2596,"twenty":8.758254,"median":20.717402,"eighty":46.357488,"marketCap":64091525617},{"date":"2025-04-17","current":17.642281,"twenty":8.758794,"median":20.705001,"eighty":46.234928,"marketCap":65669735088},{"date":"2025-04-25","current":18.971902,"twenty":8.757715,"median":20.631385,"eighty":45.993268,"marketCap":70679960108},{"date":"2025-05-02","current":19.027519,"twenty":8.758254,"median":20.543459,"eighty":45.790243,"marketCap":71037833324},{"date":"2025-05-09","current":18.60931,"twenty":8.757715,"median":20.427733,"eighty":45.434847,"marketCap":69964213677},{"date":"2025-05-16","current":19.119426,"twenty":8.757715,"median":20.391805,"eighty":44.686655,"marketCap":72469326187},{"date":"2025-05-23","current":19.674285,"twenty":8.757715,"median":20.317327,"eighty":41.07031,"marketCap":74795502089},{"date":"2025-05-30","current":20.853432,"twenty":8.757715,"median":20.194397,"eighty":35.483307,"marketCap":79626790502},{"date":"2025-06-06","current":21.257091,"twenty":8.757715,"median":20.194397,"eighty":34.895645,"marketCap":81375206580},{"date":"2025-06-13","current":25.825329,"twenty":8.757715,"median":20.194397,"eighty":34.568065,"marketCap":98902174152},{"date":"2025-06-20","current":23.349274,"twenty":8.757715,"median":20.194397,"eighty":34.239735,"marketCap":89244457327},{"date":"2025-06-27","current":24.730575,"twenty":8.758254,"median":20.194879,"eighty":33.775233,"marketCap":94788702171},{"date":"2025-07-04","current":26.12919,"twenty":8.758254,"median":20.194879,"eighty":33.366035,"marketCap":100154100407},{"date":"2025-07-11","current":27.696846,"twenty":8.758254,"median":20.194879,"eighty":32.285338,"marketCap":106056038466},{"date":"2025-07-18","current":32.252633,"twenty":8.758254,"median":20.194879,"eighty":31.824254,"marketCap":123404159430},{"date":"2025-07-25","current":31.530312,"twenty":8.758254,"median":20.194879,"eighty":31.686967,"marketCap":121079153527},{"date":"2025-08-01","current":34.30382,"twenty":8.758254,"median":20.194879,"eighty":31.686967,"marketCap":130915716960},{"date":"2025-08-08","current":34.40521,"twenty":8.758254,"median":20.194879,"eighty":31.686967,"marketCap":131631103392},{"date":"2025-08-15","current":36.610392,"twenty":8.758254,"median":20.194879,"eighty":31.686967,"marketCap":139858047354},{"date":"2025-08-22","current":34.687938,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":146117678629},{"date":"2025-08-29","current":34.269588,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":145044598982},{"date":"2025-09-05","current":37.687413,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":159352327612},{"date":"2025-09-12","current":36.43748,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":154344622591},{"date":"2025-09-19","current":35.745075,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":151304230258},{"date":"2025-09-26","current":33.677609,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":142183053256},{"date":"2025-10-03","current":35.441166,"twenty":8.758794,"median":20.195361,"eighty":31.667486,"marketCap":149985697470},{"date":"2025-10-10","current":32.996961,"twenty":8.758254,"median":20.194879,"eighty":31.657875,"marketCap":139438431498},{"date":"2025-10-17","current":30.821158,"twenty":8.758254,"median":20.194879,"eighty":31.578552,"marketCap":130142536065},{"date":"2025-10-24","current":29.45567,"twenty":8.758254,"median":20.194879,"eighty":31.368547,"marketCap":124421985029},{"date":"2025-10-31","current":29.876643,"twenty":8.758254,"median":20.194879,"eighty":31.265465,"marketCap":126388424448},{"date":"2025-11-07","current":28.922768,"twenty":8.758254,"median":20.194879,"eighty":31.041519,"marketCap":122276778391},{"date":"2025-11-14","current":30.949306,"twenty":8.758254,"median":20.194879,"eighty":30.811192,"marketCap":131215139384},{"date":"2025-11-21","current":28.685746,"twenty":8.758254,"median":20.194879,"eighty":30.274301,"marketCap":121561709511},{"date":"2025-11-28","current":29.632732,"twenty":8.758254,"median":20.194879,"eighty":30.134809,"marketCap":126030890008},{"date":"2025-12-05","current":28.700711,"twenty":8.758254,"median":20.194879,"eighty":29.953017,"marketCap":122276778391},{"date":"2025-12-12","current":28.480192,"twenty":8.758254,"median":20.194879,"eighty":29.835297,"marketCap":121561709511},{"date":"2025-12-19","current":27.452192,"twenty":8.758254,"median":20.194879,"eighty":29.72053,"marketCap":117450063454},{"date":"2025-12-24","current":26.742133,"twenty":8.758254,"median":20.194879,"eighty":29.657539,"marketCap":114768555156},{"date":"2026-01-02","current":26.38835,"twenty":8.757715,"median":20.194397,"eighty":29.590531,"marketCap":113695951837},{"date":"2026-01-09","current":28.268047,"twenty":8.757715,"median":20.194397,"eighty":29.448545,"marketCap":122098011171},{"date":"2026-01-16","current":28.671531,"twenty":8.757715,"median":20.194397,"eighty":29.382516,"marketCap":124243217809},{"date":"2026-01-23","current":27.377668,"twenty":8.757715,"median":20.194397,"eighty":29.317338,"marketCap":118522666773},{"date":"2026-01-30","current":27.294187,"twenty":8.757715,"median":20.194397,"eighty":29.254957,"marketCap":118701433993},{"date":"2026-02-06","current":26.569105,"twenty":8.757715,"median":20.194397,"eighty":29.040648,"marketCap":115841158475},{"date":"2026-02-13","current":26.580437,"twenty":8.758254,"median":20.194879,"eighty":28.989372,"marketCap":116556227355},{"date":"2026-02-20","current":27.149521,"twenty":8.757175,"median":20.182765,"eighty":28.920647,"marketCap":118880201213}],"updateTime":1771821659545},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01177\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612250906","title":"Sino Biopharmaceutical Stock Rises 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2612250906","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612250906?lang=en_us&edition=fundamental","pubTime":"2026-02-20 16:32","pubTimestamp":1771576320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 1.8% to 6.65 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.1% to 26413.35.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 27% short of its 52-week high of HK$9.12, which the company reached Sept. 10.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 2.6% and Amgen Inc. remained unchanged.Trading volume totaled 21.0 million shares, compared to the 50-day average of 62.8 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","BK1589","BK1521","BK1191","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","01177","HK0000165453.HKD","BK1515"],"gpt_icon":0},{"id":"2611817212","title":"BRIEF-Sino Biopharmaceutical Says NMPA Approved Benmelstobart Injection For Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2611817212","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611817212?lang=en_us&edition=fundamental","pubTime":"2026-02-16 09:58","pubTimestamp":1771207080,"startTime":"0","endTime":"0","summary":"BRIEF-Sino Biopharmaceutical Says NMPA Approved Benmelstobart Injection For MarketingFeb 16 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK:APPROVAL FOR MARKETING OF BENMELSTOBART INJECTION BY CHINA'S NMPAFurther company coverage: 1177.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nFWN3ZB037:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1589","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1191","BK1521","IE00BZ08YR35.GBP","01177","BK1515"],"gpt_icon":0},{"id":"1170001351","title":"Sino Biopharm (1177) Announces Approval of Benmelstobart Injection for NSCLC Maintenance Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1170001351","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170001351?lang=en_us&edition=fundamental","pubTime":"2026-02-16 07:01","pubTimestamp":1771196505,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited (1177) reported that its independently developed national Category 1 innovative drug, benmelstobart (marketed as Andewei®), received approval from the National Medical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"gpt_icon":0},{"id":"1127037497","title":"SINO BIOPHARM's Innovative Drug Bemusubain Injection Gains Approval for New NSCLC Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1127037497","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127037497?lang=en_us&edition=fundamental","pubTime":"2026-02-16 06:42","pubTimestamp":1771195367,"startTime":"0","endTime":"0","summary":"SINO BIOPHARM announced that the new indication for the group's self-developed national Class 1 innovative drug, Bemusubain Injection (trade name: Andewei®), has received marketing approval from the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1589","01177","IE00BZ08YT58.USD","BK1191","BK1515","BK1521"],"gpt_icon":0},{"id":"2611179855","title":"Sino Biopharmaceutical -  Approval for Marketing of Benmelstobart Injection by China's Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2611179855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611179855?lang=en_us&edition=fundamental","pubTime":"2026-02-16 06:35","pubTimestamp":1771194958,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260215:nFWN3ZB037:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000165453.HKD","01177","IE00BZ08YR35.GBP","BK1191","IE00BZ08YT58.USD","BK1515","BK1589","BK1521","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"2611798591","title":"Sino Biopharmaceutical Gains NMPA Approval for Benmelstobart in Stage III NSCLC Maintenance Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2611798591","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611798591?lang=en_us&edition=fundamental","pubTime":"2026-02-16 06:35","pubTimestamp":1771194950,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited announced that the National Medical Products Administration  of China has approved a new indication for benmelstobart  injection. The approval is for maintenance therapy in patients with unresectable stage III non-small cell lung cancer  who have not progressed following platinum-based concurrent or sequential chemoradiotherapy and who do not have known EGFR sensitizing mutations or ALK rearrangements. The decision was based on positive results from the R-ALPS phase III clinical study.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260215:nNDLbkzQq1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1191","IE00BZ08YT58.USD","BK1521","HK0000165453.HKD","BK1589","01177","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2611360134","title":"Sino Biopharmaceutical Stock Slips 0.9% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2611360134","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611360134?lang=en_us&edition=fundamental","pubTime":"2026-02-13 16:33","pubTimestamp":1770971580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. dropped 0.9% to 6.52 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.7% to 26567.12.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 29% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.3% and Amgen Inc. remained unchanged.Trading volume totaled 24.0 million shares, compared to the 50-day average of 63.8 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","IE00BZ08YR35.GBP","BK1191","BK1521","01177","BK1589","HK0000165453.HKD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2610482849","title":"Sino Biopharmaceutical Stock Sheds 3.7% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2610482849","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610482849?lang=en_us&edition=fundamental","pubTime":"2026-02-12 16:31","pubTimestamp":1770885060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 3.7% to 6.58 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 27032.54.The stock's fall snapped a seven-day winning streak.Sino Biopharmaceutical Ltd. closed 28% short of its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 3.2% and Amgen Inc. remained unchanged.Trading volume totaled 32.2 million shares, compared to the 50-day average of 64.6 million shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IE00BZ08YR35.GBP","01177","BK1191","BK1515","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","HK0000165453.HKD","BK1521"],"gpt_icon":0},{"id":"1164608930","title":"Bank of America Securities Reaffirms Buy Rating on Sino Biopharm Following Positive Progress on Two Drug Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=1164608930","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164608930?lang=en_us&edition=fundamental","pubTime":"2026-02-12 16:30","pubTimestamp":1770885025,"startTime":"0","endTime":"0","summary":"Bank of America Securities has issued a research report highlighting that Sino Biopharm (01177) has recently completed patient enrollment for the Phase 3 clinical trials of its two drug candidates,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","01177","IE00BZ08YR35.GBP","BK1191","IE00BZ08YT58.USD","BK1515","161027","BK1589","BK1521","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"1181439097","title":"Small Nucleic Acids Reshape Weight Loss Paradigm with INHBE and ALK7 Targets Showing Initial Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=1181439097","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181439097?lang=en_us&edition=fundamental","pubTime":"2026-02-12 14:52","pubTimestamp":1770879137,"startTime":"0","endTime":"0","summary":"According to a research report, small nucleic acid drugs and GLP-1 based therapies demonstrate synergistic effects, with major weight loss companies already deploying small nucleic acid drug...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IE00BYV24P56.USD","IE00BZ08YS42.EUR","IE00BMCWC346.EUR","01276","LU0359201612.USD","BK0276","BK1564","01177","SG9999015986.USD","161027","LU0359202008.SGD","HK0000165453.HKD","SG9999015978.USD","LU1023057109.AUD","BK1147","BK1191","BK1521","IE00BZ08YR35.GBP","01456","601456","IE00BGHQDM52.EUR","IE00BZ08YT58.USD","BK1593","SG9999015945.SGD","LU2488822045.USD","LU2543165471.USD","IE00BVYPNQ40.USD","00867","SG9999004220.SGD","SG9999015952.SGD","IE00BVYPNP33.GBP","LU0359201885.HKD","BK1515"],"gpt_icon":0},{"id":"1163060577","title":"Stock Track | SINO BIOPHARM Soars 5.00% Intraday on Completion of Phase III Trial Enrollment for Breast Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1163060577","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163060577?lang=en_us&edition=fundamental","pubTime":"2026-02-10 10:40","pubTimestamp":1770691244,"startTime":"0","endTime":"0","summary":"SINO BIOPHARM's stock price surged 5.00% during intraday trading on Tuesday, driven by positive clinical development news.The company announced the completion of patient enrollment for a Phase III...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01177"],"gpt_icon":0},{"id":"2610937386","title":"Sino Biopharmaceutical Completes Subject Enrollment in Phase 3 Trial of Breast Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2610937386","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610937386?lang=en_us&edition=fundamental","pubTime":"2026-02-10 09:38","pubTimestamp":1770687521,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical (HKG:1177) completed subject enrollment in the phase 3 clinical trial of TQB2102 to treat a type of breast cancer, according to a Hong Kong bourse filing Tuesday.The drug was previously found to benefit patients in a phase 1b clinical study.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1589","BK1521","BK1515","01177","BK1191","HK0000165453.HKD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"1126570572","title":"Chinese Pharmaceutical Firm Completes Patient Enrollment for Phase III Trial of HER2-Targeting Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1126570572","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126570572?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:24","pubTimestamp":1770675864,"startTime":"0","endTime":"0","summary":"SINO BIOPHARM (01177) announced that the Group's self-developed Class 1 innovative drug, TQB2102, a HER2-targeting bispecific antibody-drug conjugate, has completed patient enrollment for a Phase III...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","BK1589","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK4080","BK4134","ADC","BK1521","III","BK1191","IE00BZ08YS42.EUR","HK0000165453.HKD","01177","BK1515"],"gpt_icon":0},{"id":"1170617153","title":"Sino Biopharm (1177) Completes Phase III Enrollment for TQB2102 “HER2 Bispecific ADC” in HER2-Low Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1170617153","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170617153?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:23","pubTimestamp":1770675812,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited (1177) announced that it has completed subject enrollment for a Phase III clinical trial evaluating TQB2102, described as a next-generation HER2 dual-epitope bispecific...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"gpt_icon":0},{"id":"2610186661","title":"Sino Biopharm Completes Enrollment for Phase III Trial of HER2 Bispecific ADC in HER2-Low Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2610186661","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610186661?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:10","pubTimestamp":1770675045,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL2ygQcP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IE00BZ08YR35.GBP","01177","BK1191","BK1515","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","HK0000165453.HKD","BK1521"],"gpt_icon":0},{"id":"2610680515","title":"Sino Biopharmaceutical Stock Rallies 1.9% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2610680515","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610680515?lang=en_us&edition=fundamental","pubTime":"2026-02-09 16:33","pubTimestamp":1770625980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. advanced 1.9% to 6.60 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.8% to 27027.16.This was the stock's fifth consecutive day of gains.Sino Biopharmaceutical Ltd. closed 28% short of its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.2% and Amgen Inc. remained unchanged.Trading volume totaled 51.7 million shares, compared to the 50-day average of 64.3 million shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1521","BK1515","01177","BK1191","HK0000165453.HKD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2610686637","title":"BUZZ-Sino Biopharm climbs most in five weeks on cancer drug development progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2610686637","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610686637?lang=en_us&edition=fundamental","pubTime":"2026-02-09 14:11","pubTimestamp":1770617484,"startTime":"0","endTime":"0","summary":"BUZZ-Sino Biopharm climbs most in five weeks on cancer drug development progress** Shares of Sino Biopharmaceutical 1177.HK climb 3.7% to HK$6.72, on course for the biggest one-day pct rise since January 7 ** Stock hits highest since January 30 on its fifth straight session of gain** Company said its unit's drug has completed patient enrollment in its Phase III registrational clinical trial for treatment of metastatic gastric and gastroesophageal junction adenocarcinoma  ** YTD, stock up 7.6%, Hang Seng Biotech Index .HSBIO up 9.4%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nL1N3Z505U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","IE00BZ08YR35.GBP","BK1191","BK1515","IE00BZ08YT58.USD","BK1521","01177","IE00BZ08YS42.EUR","BK1589"],"gpt_icon":0},{"id":"1115028712","title":"SINO BIOPHARM (01177): Patient Enrollment Completed for Phase III Trial of Claudiximab \"CLDN18.2 ADC\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1115028712","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115028712?lang=en_us&edition=fundamental","pubTime":"2026-02-09 06:22","pubTimestamp":1770589355,"startTime":"0","endTime":"0","summary":"SINO BIOPHARM (01177) announced that its wholly-owned subsidiary, Linnovation Pharma Tech (Shanghai) Co., Ltd., has successfully completed patient enrollment for the Phase III registrational clinical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","ADC","III","BK4080","BK1191","IE00BZ08YR35.GBP","BK1515","HK0000165453.HKD","01177","BK1589","BK4134","IE00BZ08YT58.USD","BK4231","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"1194893261","title":"Sino Biopharmaceutical (1177) Announces Completion of Phase III Enrollment for Tecotabart Vedotin “CLDN18.2 ADC”","url":"https://stock-news.laohu8.com/highlight/detail?id=1194893261","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194893261?lang=en_us&edition=fundamental","pubTime":"2026-02-09 06:21","pubTimestamp":1770589275,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited (1177) announced that tecotabart vedotin (LM-302), an innovative “CLDN18.2 ADC” drug independently developed by its wholly owned subsidiary, LaNova Medicines, has...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"gpt_icon":0},{"id":"2610508778","title":"Sino Biopharmaceutical Completes Phase III Enrollment for Tecotabart Vedotin in Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2610508778","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610508778?lang=en_us&edition=fundamental","pubTime":"2026-02-09 06:13","pubTimestamp":1770588830,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited has announced the completion of patient enrollment in the Phase III registrational clinical trial of tecotabart vedotin , an antibody-drug conjugate  targeting CLDN18.2, for the treatment of third-line and later CLDN18.2-positive locally advanced or metastatic gastric and gastroesophageal junction adenocarcinoma. LM-302 is the world’s first CLDN18.2 ADC to reach this stage in a registrational trial. The latest results from a study evaluating LM-302 in combination with toripalimab for the treatment of gastric cancer were presented at the 2025 American Society of Clinical Oncology  Annual Meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content us","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260208:nNDLqMvT0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1521","BK1515","01177","BK1191","HK0000165453.HKD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":169,"code":"91000000","status":"200"}]}}